|

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

RECRUITINGSponsored by Groupe Hospitalier Pitie-Salpetriere
Actively Recruiting
SponsorGroupe Hospitalier Pitie-Salpetriere
Started2026-01-01
Est. completion2029-12-31
Eligibility
Healthy vol.Accepted

Summary

ELDORA is a non-interventional observational data-science study aiming to develop and validate clinical-grade artificial intelligence tools applied to electrocardiogram (ECG) data. The project will standardize heterogeneous ECGs, create the ECGInsight harmonized database, and train interpretable models for life-threatening arrhythmia risk prediction, especially Torsades-de-Pointes/long QT syndrome and immune checkpoint inhibitor (ICI)-induced myocarditis. The project uses existing and ongoing national and international ECG cohorts with de-identified clinical metadata; AI outputs are intended for research/model development and are not used to drive patient care during the study.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* subjects included in participating existing or ongoing ECG cohorts made available to ECGInsight
* availability of ECG data (digital waveform or scanned/paper ECG suitable for digitization) and relevant clinical/demographic metadata
* data use permitted by applicable ethical, regulatory, contractual and GDPR requirements.

Exclusion Criteria:

* datasets or individual records for which required approvals, data-sharing agreements, de-identification/anonymization, or minimum ECG/metadata quality requirements are not met. No interventional study treatment is assigned.

Conditions4

ArrhythmiaHeart DiseaseImmune Checkpoint Inhibitor-Related MyocarditisLong QT Syndrome

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.